UK markets open in 40 minutes

Reneo Pharmaceuticals, Inc. (RPHM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.8100-0.0500 (-2.69%)
At close: 04:00PM EDT
1.8100 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
50,564
56,613
37,705
28,169
15,944
Selling general and administrative
25,930
26,440
16,143
11,649
3,608
Total operating expenses
76,494
83,053
53,848
39,818
19,552
Operating income or loss
-76,494
-83,053
-53,848
-39,818
-19,552
Total other income/expenses net
5,787
5,665
1,893
48
87
Income before tax
-70,707
-77,388
-51,955
-39,770
-19,465
Income from continuing operations
-70,707
-77,388
-51,955
-39,770
-19,465
Net income
-70,707
-77,388
-51,955
-39,770
-19,465
Net income available to common shareholders
-70,707
-77,388
-51,955
-39,770
-19,465
Basic EPS
-2.36
-
-2.12
-2.19
-0.80
Diluted EPS
-2.36
-
-2.12
-2.19
-0.80
Basic average shares
28,431
-
24,496
18,143
24,211
Diluted average shares
28,431
-
24,496
18,143
24,211